Last Updated on: 21st November 2023, 10:29 pm
Abingdon Health is proud to launch the Salistick TM saliva pregnancy test, a revolutionary product that is set to transform the field of pregnancy testing in the UK and Ireland. Representing the first major advancement in pregnancy testing worldwide in decades, this patented technology allows for the detection of the pregnancy hormone hCG in saliva, providing women with a more convenient and hygienic testing experience.
Traditionally, pregnancy tests have relied on detecting hCG in urine samples. However, the Salistick TM test harnesses the power of saliva, offering a sensitive and reliable method of detecting hCG. Shortly after fertilisation, the female body begins to produce hCG, and a portion of this hormone can be detected in saliva. With the Salistick TM saliva pregnancy test, women now have the flexibility to test whenever and wherever they prefer, while also being able to share this special moment with their partners and loved ones.
This cutting-edge technology, developed by Salignostics Limited, an innovative Israeli company specialising in rapid diagnostics, transforms saliva into a reliable body-fluid sample for lateral flow immunoassays. Abingdon Health PLC is proud to partner with Superdrug, a popular health and beauty retailer in the UK, for the launch of the Salistick TM Saliva Pregnancy Test. The test will be available online at Abingdon Simply Test and Superdrug.com, as well as in 400 Superdrug stores.
Guy Krief, PhD, Deputy CEO and Chief Business Development Officer at Salignostics Ltd, expressed his excitement about the availability of Salistick TM kits in the Superdrug network, marking a significant milestone in Salignostics’ market expansion across the UK and Ireland. This groundbreaking innovation represents a pivotal moment in the evolution of pregnancy home-testing, reaching millions of women.
For Abingdon Health PLC, the launch of the Salistick TM saliva pregnancy test is a momentous achievement. The company, based in York, continues to expand its portfolio of innovative testing options available in stores nationwide and online via abingdonsimplytest.com. By prioritising user experiences and delivering high-quality products, Abingdon Health PLC remains at the forefront of the industry.
Chris Yates, CEO at Abingdon Health PLC, expressed his delight about the launch of Salistick TM and the partnership with Superdrug. This novel technology offers women an enhanced user experience, allowing them to test anywhere, anytime, and share the testing experience with their partners and loved ones.
This groundbreaking development in pregnancy testing is set to revolutionise the industry and provide women with a more convenient and inclusive approach to testing for pregnancy.
